300015 爱尔眼科
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)15.18117.97318.90918.04221.956
总资产报酬率 ROA (%)9.26711.21011.83410.42512.428
投入资产回报率 ROIC (%)11.22813.46014.45513.01615.742

边际利润分析
销售毛利率 (%)47.11348.11750.79350.46351.923
营业利润率 (%)20.59322.99524.29421.94023.292
息税前利润/营业总收入 (%)20.58422.91722.70620.74321.693
净利润/营业总收入 (%)15.53817.80617.95016.69216.465

收益指标分析
经营活动净收益/利润总额(%)104.88994.769115.445118.663127.519
价值变动净收益/利润总额(%)3.91911.920-0.723-9.385-9.762
营业外收支净额/利润总额(%)-4.022-5.020-8.722-5.980-11.000

偿债能力分析
流动比率 (X)1.2381.4501.6941.7991.150
速动比率 (X)1.1181.3021.5451.6631.059
资产负债率 (%)36.20334.41033.66333.72444.052
带息债务/全部投入资本 (%)9.3559.0037.5856.72315.026
股东权益/带息债务 (%)789.464822.723999.5261,147.917438.025
股东权益/负债合计 (%)165.494181.019185.555185.995117.504
利息保障倍数 (X)26.14322.43962.811502.14530.572

营运能力分析
应收账款周转天数 (天)30.93833.38930.77634.62435.184
存货周转天数 (天)29.94031.17029.28829.37426.603